Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Intangibles (2016 - 2026)

Lexaria Bioscience's Intangibles history spans 12 years, with the latest figure at $318058.0 for Q1 2026.

  • Quarterly results put Intangibles at $318058.0 for Q1 2026, up 674.77% from a year ago — trailing twelve months through Feb 2026 was $318058.0 (up 674.77% YoY), and the annual figure for FY2025 was $75106.0, down 85.46%.
  • Intangibles for Q1 2026 was $318058.0 at Lexaria Bioscience, up from $5099.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $549122.0 in Q2 2023 to a low of $5099.0 in Q4 2025.
  • The 5-year median for Intangibles is $411452.0 (2022), against an average of $300436.0.
  • The sharpest move saw Intangibles soared 1437.25% in 2024, then plummeted 98.99% in 2025.
  • Year by year, Intangibles stood at $500549.0 in 2022, then crashed by 92.0% to $40026.0 in 2023, then surged by 1162.61% to $505373.0 in 2024, then plummeted by 98.99% to $5099.0 in 2025, then surged by 6137.65% to $318058.0 in 2026.
  • According to Business Quant data, Intangibles over the past three periods came in at $318058.0, $5099.0, and $75106.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.